Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Steen

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Arthritis Care & Research|July 2, 2025
ReplyMatthew Lammi, Kathleen D Kolstad, Lesley Ann Saketkoo, et al.
Chest|July 14, 2004
Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesMichael McGoon, David Gutterman, Virginia Steen, et al.
Rheumatology (Oxford, England)|January 28, 2021
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial designRobyn T Domsic, Shiyao Gao, Maureen Laffoon, et al.
Journal of Scleroderma and Related Disorders|June 6, 2025
Cognitive debriefing of the Scleroderma Health Assessment Questionnaire in diffuse cutaneous systemic sclerosisDinesh Khanna, George J Greene, Chelsea Rose Perschon, et al.
Seminars in Arthritis and Rheumatism|July 27, 2015
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) RegistryMonique Hinchcliff, Saira Khanna, Vivien M Hsu, et al.
Clinical and Experimental Rheumatology|September 1, 2020
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trialsCosimo Bruni, Donald P Tashkin, Virginia Steen, et al.
Arthritis Care & Research|July 14, 2025
Late-Onset Scleroderma Renal Crisis Does Occur - A Multi-Center StudySwati Mehta, Sumbal Wajid, Isam Albaba, et al.
Rheumatology (Oxford, England)|August 29, 2022
A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trialsRobyn T Domsic, Thomas A Medsger, Shiyao Gao, et al.
Clinical Rheumatology|August 27, 2013
Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)Luiza F Rocha, Roberta G Marangoni, Percival D Sampaio-Barros, et al.
The Journal of Rheumatology|August 17, 2013
Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohortsHeather Gladue, Virginia Steen, Yannick Allanore, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Arthritis Care & Research|July 2, 2025
ReplyMatthew Lammi, Kathleen D Kolstad, Lesley Ann Saketkoo, et al.
Chest|July 14, 2004
Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesMichael McGoon, David Gutterman, Virginia Steen, et al.
Rheumatology (Oxford, England)|January 28, 2021
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial designRobyn T Domsic, Shiyao Gao, Maureen Laffoon, et al.
Journal of Scleroderma and Related Disorders|June 6, 2025
Cognitive debriefing of the Scleroderma Health Assessment Questionnaire in diffuse cutaneous systemic sclerosisDinesh Khanna, George J Greene, Chelsea Rose Perschon, et al.
Seminars in Arthritis and Rheumatism|July 27, 2015
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) RegistryMonique Hinchcliff, Saira Khanna, Vivien M Hsu, et al.
Clinical and Experimental Rheumatology|September 1, 2020
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trialsCosimo Bruni, Donald P Tashkin, Virginia Steen, et al.
Arthritis Care & Research|July 14, 2025
Late-Onset Scleroderma Renal Crisis Does Occur - A Multi-Center StudySwati Mehta, Sumbal Wajid, Isam Albaba, et al.
Rheumatology (Oxford, England)|August 29, 2022
A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trialsRobyn T Domsic, Thomas A Medsger, Shiyao Gao, et al.
Clinical Rheumatology|August 27, 2013
Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)Luiza F Rocha, Roberta G Marangoni, Percival D Sampaio-Barros, et al.
The Journal of Rheumatology|August 17, 2013
Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohortsHeather Gladue, Virginia Steen, Yannick Allanore, et al.
Pageof 9